MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.360
+0.130 (5.83%)
At close: Mar 9, 2026, 4:00 PM EDT
2.390
+0.030 (1.27%)
After-hours: Mar 9, 2026, 5:44 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $149.29 million as of March 9, 2026. Its market cap has decreased by -17.43% in one year.
Market Cap
149.29M
Enterprise Value
39.59M
1-Year Change
-17.43%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $149.29M, a decrease of -75.13%. That is a compound annual growth rate of -10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 141.10M | 38.61% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 151.10M |
| Zentalis Pharmaceuticals | 148.60M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| Unicycive Therapeutics | 141.63M |
| Artiva Biotherapeutics | 140.89M |
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |
| Adagene | 133.85M |